✦ LIBER ✦

PAR24 COST-UTILITY ANALYSIS OF RITUXIMAB TREATMENT IN RHEUMATOID ARTHRITIS AFTER ANTI-TNF-ALFATHERAPY IN HUNGARY

✍ Scribed by V Brodszky; M Péntek; K Karpati; I Boncz; A Sebestyén; L Gulácsi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS51 A Cost Utility Analysis of Anti-TN

✍ R.C. Adams; C. Walsh; S. Schmitz; P. Barton; M. Barry 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PAR10 COST-EFFECTIVENESS AND COST-UTILIT

✍ M Eandi; O Zaniolo; S Iannazzo; L Pradelli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PAR6 COST-UTILITY ANALYSIS OF RITUXIMAB

✍ B Mistry; J McCormick; A Diamantopoulos; A Kielhorn 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Cost-effectiveness analysis of rituximab

✍ Sonja Merkesdal; Timm Kirchhoff; Diane Wolka; Gunter Ladinek; Adrian Kielhorn; A 📂 Article 📅 2009 🏛 Springer 🌐 French ⚖ 293 KB

PMS27 COST CONSEQUENCE ANALYSIS OF RITUX

✍ A Hammerman; SH Klang; N Liebermann; T Birenboim-Gal; A Shuali; M Kfir 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

PMS38 COST-EFFECTIVENESS OF RITUXIMAB VE

✍ F Carlos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB